Dr. Raed Zuhour, MD

Dr. Zuhour practices at University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System.

Dr. Zuhour's NPI, 1972965507, was assigned on March 23, 2016. Dr. Zuhour holds Ohio license 35.142363.

Dr. Zuhour's primary practice is University Hospitals Cleveland Medical Center, at 11100 Euclid Avenue, Cleveland, OH 44106 in Cuyahoga County. The practice phone is (216) 844-1000.

Dr. Zuhour's primary practice is University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System. Dr. Zuhour is also affiliated with University Hospitals Ahuja Medical Center. The medical group on file is University Hospitals Medical Practices. Dmand AI also links Dr. Zuhour to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zuhour practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Zuhour's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Zuhour's licenses on file in 3 states: Ohio, Kansas and Texas.

CMS data shows 1,517 Medicare services from Dr. Zuhour across 16 procedure codes in 2024, for 182 Medicare patients. Medicare paid $105,367 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 182 Medicare patients who saw Dr. Zuhour in 2024. The largest group is 65 to 74, with 99 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zuhour's median patient age at 71, with 40% women.

In 2024, Dr. Zuhour wrote 222 Medicare Part D claims for 81 patients. 95% of them were for generic drugs. CMS names the drug for 134 of them, across 4 drugs with 11 or more claims each, at $1,439 in total drug cost. In 2023, CMS named 66 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Zuhour for performance year 2024, reported as part of a group. Dr. Zuhour accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zuhour as offering telehealth.

Dmand AI links 10 papers to Dr. Zuhour, published from 2019 to 2025. 2020 was the busiest year, with 2. The most frequent topics are Prostatic Neoplasms. Dr. Zuhour's most frequent co-authors are Daniel E. Spratt, MD, Andrew M. Farach, MD and Waqar M. Haque.

CMS Open Payments shows 24 general payments to Dr. Zuhour from 17 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Novocure Inc. paid the most, $164.